Health Recce Pharmaceuticals advances R327 as diabetes and antibiotic resistance burdens converge By Proactive 02/09
Health Inside Biotech: ENA Respiratory secures A$2.98 million to advance INNA-051 asthma study By Jonathan Jackson 02/09
Health Recce Pharmaceuticals advances R327 as diabetes and antibiotic resistance burdens converge By Ephrem Joseph 02/09
Health CSL shares rise as US pricing and manufacturing deals ease policy uncertainty By Jonathan Jackson 01/09
Health Percheron Therapeutics targets blood cancer opportunity as next-generation immunotherapy moves toward clinic By Ephrem Joseph 01/09
Health Optiscan launches US head and neck cancer study with Mayo Clinic to support FDA submissions By Jonathan Jackson 01/09
Health Actinogen Medical secures $4.77 million option underwriting ahead of pivotal Alzheimer’s trial results By Ephrem Joseph 01/09
Health Percheron Therapeutics raises $2.3 million to fully fund Vanderbilt AML clinical trial By Jonathan Jackson 01/09
Mining Small Cap Watch: XSO extends decline as Percheron funds AML trial and Nova advances US antimony plans By Ephrem Joseph 01/09
Health Percheron Therapeutics receives $700,000 R&D rebate to support HMBD-002 cancer program By Jonathan Jackson 31/08
Health Percheron Therapeutics partners with Vanderbilt Health for HMBD-002 leukaemia trial By Ephrem Joseph 28/08
Health Actinogen Medical eyes pivotal November Alzheimer’s trial results after key FY2026 milestones By Jonathan Jackson 27/08
Health Prescient Therapeutics targets $7M SPP as PTX-100 approaches key Phase 2a review - ICYMI By Jonathan Jackson 27/08
Health Entropy Neurodynamics sets up US Phase 2 head-to-head trial of TRP-8803 against leading antidepressant By Jonathan Jackson 26/08
Health Lumos Diagnostics sets up US growth push after landmark year for FebriDx By Ephrem Joseph 26/08
Health Prescient Therapeutics opens $7 million share purchase plan to advance PTX-100 By Ephrem Joseph 26/08
Health Prescient Therapeutics targets $7 million raise to advance PTX-100 cancer program By Jonathan Jackson 25/08
Finance ASX SMIDcaps Conference to showcase small and mid-cap opportunities on September 23 By Jonathan Jackson 24/08
Health Recce Pharmaceuticals secures HREC approval for expanded Phase 3 diabetic foot infection trial By Jonathan Jackson 19/08
